US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Abivax S.A.

6.65

+0.54008.84%

Volume:212.78K

Turnover:1.39M

Market Cap:421.97M

PE:-2.09

High:6.75

Open:6.27

Low:6.20

Close:6.11

Loading ...

Overview Company News Filings

Guggenheim Sticks to Their Buy Rating for Abivax SA Sponsored ADR (ABVX)

European Equities Traded in the US as American Depositary Receipts Edge Higher Wednesday

MT Newswires Live

European Equities Traded in the US as American Depositary Receipts Slide Friday

MT Newswires Live

European Equities Traded in the US as American Depositary Receipts Rise Wednesday

MT Newswires Live

European Equities Traded in the US as American Depositary Receipts Edge Higher Monday

MT Newswires Live

European Equities Traded in the US as American Depositary Receipts Advance Friday

MT Newswires Live

Abivax SA expected to post a loss of 73 cents a share - Earnings Preview

Abivax publishes financial reports with the French and U.S. securities regulatory agencies

Abivax FY24 Net loss Stood At €(176.2)M Vs. €(147.8)M In FY23

Abivax Cash Position Stood At €144M As Of December 31, 2024

Abivax SA expected to post a loss of 68 cents a share - Earnings Preview

Abivax SA Sponsored ADR (ABVX) Gets a Buy from Piper Sandler

Piper Sandler Sticks to Their Buy Rating for Abivax SA Sponsored ADR (ABVX)

Morgan Stanley Sticks to Its Hold Rating for Abivax SA Sponsored ADR (ABVX)

Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress

Analysts Offer Insights on Healthcare Companies: IGM Biosciences (IGMS) and Abivax SA Sponsored ADR (ABVX)

Abivax Reaches 82% Enrollment in Phase 3 Ulcerative Colitis Trial

MT Newswires Live

Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ABVX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ABVX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABVX\",,,,,undefined,":{"symbol":"ABVX","market":"US","secType":"STK","nameCN":"Abivax S.A.","latestPrice":6.65,"timestamp":1750795200000,"preClose":6.11,"halted":0,"volume":212776,"delay":0,"floatShares":27533344,"shares":63454205,"eps":-3.17854,"marketStatus":"Pre-Mkt","change":0.54,"latestTime":"06-25 08:12:11 EDT","open":6.27,"high":6.75,"low":6.2001,"amount":1391694.4798,"amplitude":0.09,"askPrice":6.73,"askSize":20,"bidPrice":6.62,"bidSize":1010,"shortable":3,"etf":0,"ttmEps":-3.17854,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1750858200000},"marketStatusCode":1,"adr":0,"adrRate":1,"listingDate":1697774400000,"exchange":"NASDAQ","adjPreClose":6.65,"postHourTrading":{"tag":"盘后","latestPrice":6.65,"preClose":6.65,"latestTime":"16:00 EDT","volume":9,"amount":59.85,"timestamp":1750795208060},"volumeRatio":0.7711091380495809},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABVX\",,,,,undefined,":{"symbol":"ABVX","floatShares":27533344,"roa":"-48.60%","roe":"-196.12%","lyrEps":-2.894125,"volumeRatio":0.7711091380495809,"shares":63454205,"dividePrice":0,"high":6.75,"amplitude":0.09,"preClose":6.11,"low":6.2001,"week52Low":4.77,"pbRate":"-55.19","psRate":"34.36","week52High":14.16,"institutionHeld":0,"latestPrice":6.65,"committee":0.961165,"eps":-3.17854,"divideRate":0,"volume":212776,"delay":0,"ttmEps":-3.17854,"open":6.27,"prevYearClose":7.32,"prevWeekClose":5.97,"prevMonthClose":6.02,"prevQuarterClose":6.25,"fiveDayClose":6.72,"twentyDayClose":5.67,"sixtyDayClose":6.82},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ABVX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2545172384","title":"Guggenheim Sticks to Their Buy Rating for Abivax SA Sponsored ADR (ABVX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2545172384","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545172384?lang=en_us&edition=fundamental","pubTime":"2025-06-21 01:55","pubTimestamp":1750442112,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Yatin Suneja reiterated a Buy rating on Abivax SA Sponsored ADR (ABVX – Research Report) on June 16 and set a price target of $5...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-their-buy-rating-for-abivax-sa-sponsored-adr-abvx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-their-buy-rating-for-abivax-sa-sponsored-adr-abvx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVX","AAVXF"],"gpt_icon":0},{"id":"2544490626","title":"European Equities Traded in the US as American Depositary Receipts Edge Higher Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2544490626","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544490626?lang=en_us&edition=fundamental","pubTime":"2025-06-18 23:15","pubTimestamp":1750259746,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were edging up on Wednesday morning, up nearly 0.1% to 1,466.83 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by steel producer ArcelorMittal  and bank Banco Bilbao Vizcaya Argentaria , which rose 2.3% and 1.6% respectively.They were followed by bank Banco Santander , up 1.2%.The decliners from continental Europe were led by clinical-stage biotechnology firm Abivax  and biotech company BioNTech , which were shedding 2.2% and 0.1%, respectively.From the UK and Ireland, the gainers were led by biotech companies Bicycle Therapeutics  and Centessa Pharmaceuticals , which were rising about 4% and 3.3%, respectively.They were followed by biotech Autolus Therapeutics , up 3%.The decliners from the UK and Ireland were led by biotech Akari Therapeutics  and energy giant BP , which lost 5.1% and 1.6%, respectively.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BCYC","AUTL","LU1829250122.USD","AFG","BK4551","LU0320765646.SGD","BK4535","LU0162691827.USD","MT","BK4007","LU0072461881.USD","SAN.AU","BK4117","ABVX","BK4548","AKTX","LU1162221912.USD","BNTX","BK4521","BK4539","BK4107","BK4561","BP","BK4207","BK4568","BK4139","BK4588","SAN","BK4585","CNTA","BK4201","BBVA","BK7142","BK4006"],"gpt_icon":0},{"id":"2543626635","title":"European Equities Traded in the US as American Depositary Receipts Slide Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2543626635","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543626635?lang=en_us&edition=fundamental","pubTime":"2025-06-13 23:11","pubTimestamp":1749827492,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were falling Friday morning, down 1.3% to 1,489.59 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech company Cellectis  and oil and gas company Equinor , which rose 4.6% and 4.1%, respectively.They were followed by late-stage biopharmaceutical company Genfit , which was up 2.9%.The decliners from continental Europe were led by biotech company Evaxion  and cybersecurity firm Wisekey , which fell 5.9% and 5.2%, respectively.They were followed by biotech company Abivax , down 5.1%, and semiconductor company ASML , shedding 2.8%.From the UK and Ireland, the gainers were led by energy giant BP  and cigarette company British American Tobacco , which rose 2.1% and 1%, respectively.The decliners from the UK and Ireland were led by cruise operator Carnival  and biotech company Bicycle Therapeutics , which were shedding 4.5% and 4.3%, respectively.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CLLS","LU1829250122.USD","BCYC","AFG","BK4107","EVAX","LU0823434740.USD","BK4565","LU0072461881.USD","IE00BD6J9T35.USD","BK4543","BK4585","BK7062","BK4139","LU0162691827.USD","BK4588","BK4142","GNFT","LU2543165471.USD","EQNR","BTI.AU","LU0097036916.USD","BP","BTI","BK4147","LU1162221912.USD","BK4117","CUK","BK4141","LU0823434583.USD","03165","LU1734074674.USD","BK4075","IE0004445239.USD","LU0345774631.USD","LU0320765646.SGD","WKEY","BK4201","LU2063271972.USD","LU0345774391.USD","ABVX"],"gpt_icon":1},{"id":"2542356405","title":"European Equities Traded in the US as American Depositary Receipts Rise Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2542356405","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542356405?lang=en_us&edition=fundamental","pubTime":"2025-06-11 23:19","pubTimestamp":1749655191,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were rising on Wednesday morning, up 0.5% to 1,497.69 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by pharmaceutical company Addex Therapeutics  and advertising company Criteo , which rose 5.1% and 2% respectively.They were followed by energy company Eni , up 1.4%.The decliners from continental Europe were led by biotech companies Abivax  and Evaxion , which fell 2.9% and 2% respectively.From the UK and Ireland, the gainers were led by biopharmaceutical company Verona Pharma  and biotech firm Bicycle Therapeutics , which gained 4.8% and 3.9% respectively.They were followed by biotech company Barinthus Biotherapeutics , which added 2%.The decliners from the UK and Ireland were led by biotech firms Akari Therapeutics  and Autolus Therapeutics , which dropped 3.5% and 3.2% respectively.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AKTX","BK4539","BK4201","BK4009","E","EVAX","BK4107","IE00BFMHRM44.USD","AFG","CRTO","BK4139","BCYC","AUTL","BK4117","BK4007","VRNA","ABVX","ADXN","BRNS"],"gpt_icon":0},{"id":"2542833511","title":"European Equities Traded in the US as American Depositary Receipts Edge Higher Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2542833511","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542833511?lang=en_us&edition=fundamental","pubTime":"2025-06-09 23:16","pubTimestamp":1749482166,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were edging up on Monday morning, with the S&P Europe Select ADR Index fractionally higher at 1,481.60.From continental Europe, the gainers were led by cybersecurity firm Wisekey  and semiconductor company ASML , which rose 15% and 3.5%, respectively.They were followed by specialty vaccine company Valneva , which added 1.6%, and energy company Equinor , up 0.7%.The decliners from continental Europe were led by biotech firms Abivax  and Evaxion , which fell 4.9% and 2.2%, respectively.They were followed by advertising company Criteo , down 1%.From the UK and Ireland, the gainers were led by semiconductor company Arm  and beverage giant Diageo , which rose 5% and 1.4%, respectively.They were followed by software development company Endava , up 1.3%.The decliners from the UK and Ireland were led by biotech companies Immunocore  and Autolus Therapeutics , which fell 3.5% and 2.4%, respectively.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4505","AUTL","IE00BD6J9T35.USD","LU0084288595.USD","LU0345774391.USD","AFG","CRTO","BK4134","IE00BMPRXN33.USD","LU0823434740.USD","WKEY","BK4543","LU1734074674.USD","03165","EQNR","BK4139","LU0648005311.SGD","ASML","BK4559","IE00BMPRXR70.SGD","BK4169","BK4585","BK4539","ABVX","BK4201","BK4609","DAVA.AU","LU2063271972.USD","BK4117","DAVA","BK4009","DEO","LU0097036916.USD","BK4141","BK4565","LU0345774631.USD","LU0348723411.USD","BK4147","EVAX","LU0823434583.USD","IE0004445239.USD","BK4588","ARM.AU","IE00BFMHRM44.USD","VALN","ARM","IE00BMPRXQ63.HKD","IMCR","DGE.UK","BK4107"],"gpt_icon":1},{"id":"2541869797","title":"European Equities Traded in the US as American Depositary Receipts Advance Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2541869797","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541869797?lang=en_us&edition=fundamental","pubTime":"2025-06-06 23:29","pubTimestamp":1749223764,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were rising on Friday morning, up 0.51% to 1,479.70 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech companies Evaxion  and Abivax , which rose past 20.1% and 3.3%, respectively. They were followed by cybersecurity firm Wisekey  and semiconductor company ASML , which added 2.8% and 1.4%.The decliners from continental Europe were led by clinical-stage biotech research firm Genenta Science  and late-stage biopharmaceutical company Genfit , which fell 7% and 6.5% respectively.From the UK and Ireland, the gainers were led by biotech firms Compass Pathways  and Autolus Therapeutics , which rose 5.1% and 4.8% respectively. They were followed by semiconductor company Arm , which increased 3.8%.The decliners from the UK and Ireland were led by clinical-stage biopharmaceutical company Verona Pharma , which retreated 3.1%.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4543","LU0348723411.USD","LU0345774631.USD","WKEY","ARM","BK4588","BK4609","IE00BMPRXR70.SGD","LU0823434583.USD","IE0004445239.USD","VRNA","CMPS","BK4147","IE00BMPRXN33.USD","BK4585","BK4107","ABVX","LU2063271972.USD","BK4117","LU0097036916.USD","AUTL","IE00BMPRXQ63.HKD","LU0823434740.USD","AFG","ARM.AU","IE00BD6J9T35.USD","LU0345774391.USD","03165","BK4141","BK4565","GNFT","EVAX","LU1734074674.USD","BK4007","GNTA","BK4139"],"gpt_icon":1},{"id":"2539784742","title":"Abivax SA  expected to post a loss of 73 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2539784742","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539784742?lang=en_us&edition=fundamental","pubTime":"2025-05-30 22:02","pubTimestamp":1748613769,"startTime":"0","endTime":"0","summary":"Abivax SA  expected to post a loss of73cents a share - Earnings Preview Abivax SA ABVX.OQ, ABVX.O is expected to report resultson June 2 for the period ending March 31 2025The Paris Ile-de-france-base","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nL5N3S20ZO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Abivax SA  expected to post a loss of 73 cents a share - Earnings Preview","news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"gpt_icon":0},{"id":"2522356175","title":"Abivax publishes financial reports with the French and U.S. securities regulatory agencies","url":"https://stock-news.laohu8.com/highlight/detail?id=2522356175","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522356175?lang=en_us&edition=fundamental","pubTime":"2025-03-27 05:05","pubTimestamp":1743023100,"startTime":"0","endTime":"0","summary":"PARIS, France – March 26, 2025 – 10:05 PM CET – Abivax SA  , a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases, announces the filing of its Universal Registration Document  with the French Financial Market Authorities, Autorité des Marchés Financiers , and the filing of its Annual Report  with the U.S. Securities and Exchange Commission  on March 24, 2025.The Universal Registration Document includes the 2024 annual financial report, the management report including the report on corporate governance, as well as the reports of the statutory auditors.Abivax is a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Based in France and the United States, Abivax’s lead drug candidate, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/abivax-publishes-financial-reports-french-210500560.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AAVXF","BK4139","ABVX"],"gpt_icon":0},{"id":"2521762826","title":"Abivax FY24 Net loss Stood At €(176.2)M Vs. €(147.8)M In FY23","url":"https://stock-news.laohu8.com/highlight/detail?id=2521762826","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521762826?lang=en_us&edition=fundamental","pubTime":"2025-03-24 15:39","pubTimestamp":1742801960,"startTime":"0","endTime":"0","summary":"Abivax FY24 Net loss Stood At €(176.2)M Vs. €(147.8)M In FY23","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44452526/abivax-fy24-net-loss-stood-at-176-2-m-vs-147-8-m-in-fy23","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABVX"],"gpt_icon":0},{"id":"2521762830","title":"Abivax Cash Position Stood At €144M As Of December 31, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2521762830","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521762830?lang=en_us&edition=fundamental","pubTime":"2025-03-24 15:36","pubTimestamp":1742801814,"startTime":"0","endTime":"0","summary":"Abivax Cash Position Stood At €144M As Of December 31, 2024","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44452503/abivax-cash-position-stood-at-144m-as-of-december-31-2024","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX","BK4139"],"gpt_icon":0},{"id":"2521157235","title":"Abivax SA  expected to post a loss of 68 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2521157235","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521157235?lang=en_us&edition=fundamental","pubTime":"2025-03-21 23:02","pubTimestamp":1742569345,"startTime":"0","endTime":"0","summary":"Abivax SA  expected to post a loss of68cents a share - Earnings Preview Abivax SA ABVX.OQ, ABVX.O is expected to report resultson March 24 for the period ending September 30 2024The Paris Ile-de-franc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nL8N3Q41IA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"gpt_icon":0},{"id":"2518480432","title":"Abivax SA Sponsored ADR (ABVX) Gets a Buy from Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2518480432","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518480432?lang=en_us&edition=fundamental","pubTime":"2025-03-10 17:45","pubTimestamp":1741599918,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Allison Bratzel maintained a Buy rating on Abivax SA Sponsored ADR (ABVX – Research Report) on March 7 and set a price target...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/abivax-sa-sponsored-adr-abvx-gets-a-buy-from-piper-sandler?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/abivax-sa-sponsored-adr-abvx-gets-a-buy-from-piper-sandler?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVX","BK4139","AAVXF"],"gpt_icon":0},{"id":"2510774853","title":"Piper Sandler Sticks to Their Buy Rating for Abivax SA Sponsored ADR (ABVX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2510774853","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510774853?lang=en_us&edition=fundamental","pubTime":"2025-02-10 19:45","pubTimestamp":1739187952,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Christopher Raymond maintained a Buy rating on Abivax SA Sponsored ADR (ABVX – Research Report) today and set a price target ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-their-buy-rating-for-abivax-sa-sponsored-adr-abvx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-their-buy-rating-for-abivax-sa-sponsored-adr-abvx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AAVXF","ABVX"],"gpt_icon":0},{"id":"2506518788","title":"Morgan Stanley Sticks to Its Hold Rating for Abivax SA Sponsored ADR (ABVX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2506518788","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506518788?lang=en_us&edition=fundamental","pubTime":"2025-01-28 20:56","pubTimestamp":1738068997,"startTime":"0","endTime":"0","summary":"In a report released today, Vikram Purohit from Morgan Stanley maintained a Hold rating on Abivax SA Sponsored ADR (ABVX – Research Report), with a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-its-hold-rating-for-abivax-sa-sponsored-adr-abvx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":"a4f53057487a84b640754ed046ea1dd3","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-its-hold-rating-for-abivax-sa-sponsored-adr-abvx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVX","AAVXF"],"gpt_icon":0},{"id":"2505293100","title":"Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2505293100","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505293100?lang=en_us&edition=fundamental","pubTime":"2025-01-24 05:05","pubTimestamp":1737666300,"startTime":"0","endTime":"0","summary":"Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress. PARIS, France – January 23, 2025 – 10:05 PM CET – Abivax SA  , a clinical-stage biotechnology company developing innovative therapies to address chronic inflammatory diseases, today announced that seven scientific abstracts on its lead drug candidate, obefazimod, [an investigational, orally administered, once-daily small molecule] in clinical development for the treatment of moderately to severely active ulcerative colitis , will be presented at The European Crohn’s and Colitis Organization’s  20th Annual Congress as part of scientific exchange, taking place February 19-22, 2025, in Berlin, Germany.“With 7 abstracts accepted for presentation at ECCO 2025, we look forward to our continued exchange with the inflammatory bowel disease community around the emerging clinical profile of obefazimod,” said Fabio Cataldi, MD, Chief Medical","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/abivax-announces-presentation-seven-abstracts-210500730.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ABVX","AAVXF","BK4139"],"gpt_icon":0},{"id":"2502857293","title":"Analysts Offer Insights on Healthcare Companies: IGM Biosciences (IGMS) and Abivax SA Sponsored ADR (ABVX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2502857293","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502857293?lang=en_us&edition=fundamental","pubTime":"2025-01-10 20:30","pubTimestamp":1736512213,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on IGM Biosciences (IGMS – Research Report) and Abiva...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-igm-biosciences-igms-and-abivax-sa-sponsored-adr-abvx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-igm-biosciences-igms-and-abivax-sa-sponsored-adr-abvx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","AAVXF","BK4505","IGMS","ABVX","BK4139","IGM","HCSG"],"gpt_icon":0},{"id":"2502102699","title":"Abivax Reaches 82% Enrollment in Phase 3 Ulcerative Colitis Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2502102699","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502102699?lang=en_us&edition=fundamental","pubTime":"2025-01-10 03:26","pubTimestamp":1736450794,"startTime":"0","endTime":"0","summary":"Abivax  said Thursday that it reached 82% of target enrollment in a phase 3 trial evaluating obefazimod for the treatment of moderately to severely active ulcerative colitis.Enrollment stood at 1,003 of 1,224 targeted participants and is expected to be completed in Q2, according to the biotechnology company.The company's cash runway will extend beyond the trial readout and into Q4, Abivax said.Price: 6.68, Change: -0.30, Percent Change: -4.30","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ABVX","BK4139"],"gpt_icon":0},{"id":"2502044565","title":"Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment","url":"https://stock-news.laohu8.com/highlight/detail?id=2502044565","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502044565?lang=en_us&edition=fundamental","pubTime":"2025-01-10 00:35","pubTimestamp":1736440500,"startTime":"0","endTime":"0","summary":"Phase 3 ABTECT Trial evaluating obefazimod for moderately to severely active ulcerative colitis  reaches 1,003 of 1,224 participants, representing 82% of target enrollment. Enrollment completion expected in Q2 2025.Blinded baseline characteristics align with pre-specified target population and consistent with Phase 2b UC trial. Marc de Garidel, Chief Executive Officer of Abivax, commented:“We are thrilled to announce that the ABTECT Phase 3 trial has reached a significant milestone, with over 1,000 participants enrolled, representing 82% of our targeted enrollment. This progress underscores the enthusiasm of investigators and patients for this important trial, which remains among the fastest-enrolling Phase 3 UC trials to date.”Mr. de Garidel went on to say, “In order to ensure a balanced representation of bio-nave and bio-experienced participants amid heightened competition in UC trial recruitment, we now anticipate completing enrollment in Q2 2025 and delivering top-line results for ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/abivax-achieves-key-milestone-phase-163500976.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","AAVXF","ABVX"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ABVX\",params:#limit:5,,,undefined,":[{"date":"2025-08-11","symbol":"ABVX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/06","expectedEps":-0.89,"defaultRemindTime":1754942400000,"name":null,"time":"Post Market","dateTimestamp":1754884800000,"actualEps":null},{"market":"US","date":"2025-06-02","symbol":"ABVX","fiscalQuarterEnding":"2025/03","expectedEps":-0.76,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1748836800000,"reportTimeType":"post","actualEps":-0.87},{"date":"2025-03-24","symbol":"ABVX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/12","expectedEps":-0.67,"defaultRemindTime":1742803200000,"name":null,"time":"Pre-Market","dateTimestamp":1742788800000,"actualEps":null},{"market":"US","date":"2024-11-14","symbol":"ABVX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":null},{"date":"2024-09-09","symbol":"ABVX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1725868800000,"name":null,"time":"Pre-Market","dateTimestamp":1725854400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ABVX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ABVX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.5,"hold":0.1667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":6,"updateTime":1733371200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ABVX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ABVX","date":"2025-06-24","current":-1.913072,"percent":0.939086,"low":-9.732151,"twenty":-6.681503,"median":-4.325059,"eighty":-2.254542,"high":-0.02231,"avg":-4.562229,"sd":2.28635,"marketCap":413238223.05},"quantilePoints":[{"date":"2023-10-27","current":-7.823172,"twenty":-7.328793,"median":-6.587224,"eighty":-5.845656,"marketCap":753894810.45},{"date":"2023-11-03","current":-6.291292,"twenty":-6.250217,"median":-6.06538,"eighty":-6.010614,"marketCap":611163613.59},{"date":"2023-11-10","current":-6.503512,"twenty":-6.645905,"median":-6.346058,"eighty":-6.06538,"marketCap":637532258.17},{"date":"2023-11-17","current":-7.092251,"twenty":-6.941614,"median":-6.503512,"eighty":-6.069488,"marketCap":704987904.63},{"date":"2023-11-24","current":-6.558278,"twenty":-6.982681,"median":-6.613045,"eighty":-6.085918,"marketCap":654468961.83},{"date":"2023-12-01","current":-6.469283,"twenty":-6.777344,"median":-6.486397,"eighty":-6.085918,"marketCap":645658268.08},{"date":"2023-12-08","current":-6.667811,"twenty":-6.729423,"median":-6.558278,"eighty":-6.270755,"marketCap":658292574.17},{"date":"2023-12-15","current":-6.708886,"twenty":-6.708886,"median":-6.565124,"eighty":-6.291292,"marketCap":675019398.57},{"date":"2023-12-22","current":-6.859493,"twenty":-6.749961,"median":-6.585661,"eighty":-6.304984,"marketCap":690021158.62},{"date":"2023-12-29","current":-6.722577,"twenty":-6.78282,"median":-6.609622,"eighty":-6.321414,"marketCap":681416772.26},{"date":"2024-01-05","current":-6.626736,"twenty":-6.777344,"median":-6.626736,"eighty":-6.346059,"marketCap":664561787.4},{"date":"2024-01-12","current":-6.845802,"twenty":-6.796512,"median":-6.667811,"eighty":-6.407671,"marketCap":685854313.55},{"date":"2024-01-19","current":-7.023793,"twenty":-6.859493,"median":-6.681503,"eighty":-6.435054,"marketCap":698334715.34},{"date":"2024-01-26","current":-7.986412,"twenty":-6.982718,"median":-6.681503,"eighty":-6.435054,"marketCap":792063074.67},{"date":"2024-02-02","current":-8.137618,"twenty":-7.092251,"median":-6.715732,"eighty":-6.469283,"marketCap":807847078.54},{"date":"2024-02-09","current":-7.972666,"twenty":-7.379774,"median":-6.743115,"eighty":-6.503512,"marketCap":785337680.3},{"date":"2024-02-16","current":-7.738985,"twenty":-7.738985,"median":-6.763653,"eighty":-6.503512,"marketCap":761909093.06},{"date":"2024-02-23","current":-8.385046,"twenty":-7.788813,"median":-6.78419,"eighty":-6.508989,"marketCap":829978945.38},{"date":"2024-03-01","current":-8.879901,"twenty":-7.848771,"median":-6.818419,"eighty":-6.548694,"marketCap":878391233.38},{"date":"2024-03-08","current":-8.921139,"twenty":-7.986412,"median":-6.859493,"eighty":-6.569232,"marketCap":892211380.33},{"date":"2024-03-15","current":-8.659965,"twenty":-8.228342,"median":-6.982681,"eighty":-6.577447,"marketCap":863166780.31},{"date":"2024-03-22","current":-9.319772,"twenty":-8.319065,"median":-7.010102,"eighty":-6.584292,"marketCap":926107447.06},{"date":"2024-03-28","current":-9.209804,"twenty":-8.585737,"median":-7.078559,"eighty":-6.597984,"marketCap":910336135.23},{"date":"2024-04-05","current":-9.732151,"twenty":-8.736943,"median":-7.311316,"eighty":-6.610307,"marketCap":967400801.65},{"date":"2024-04-12","current":-5.879845,"twenty":-8.706701,"median":-7.078559,"eighty":-6.566493,"marketCap":928230894.29},{"date":"2024-04-19","current":-6.030284,"twenty":-8.692955,"median":-6.99641,"eighty":-6.48982,"marketCap":950004364.47},{"date":"2024-04-26","current":-6.311356,"twenty":-8.670962,"median":-6.941624,"eighty":-6.433272,"marketCap":998864220.67},{"date":"2024-05-03","current":-5.987697,"twenty":-8.585737,"median":-6.859493,"eighty":-6.311356,"marketCap":946423801.22},{"date":"2024-05-10","current":-5.698107,"twenty":-8.470271,"median":-6.80815,"eighty":-6.289097,"marketCap":907055615.77},{"date":"2024-05-17","current":-5.502208,"twenty":-8.401541,"median":-6.777344,"eighty":-6.21545,"marketCap":883582818.48},{"date":"2024-05-24","current":-5.348896,"twenty":-8.33556,"median":-6.749961,"eighty":-6.06538,"marketCap":855336978.03},{"date":"2024-05-31","current":-5.357413,"twenty":-8.297072,"median":-6.736269,"eighty":-6.030284,"marketCap":858278233.57},{"date":"2024-06-07","current":-5.493691,"twenty":-8.288824,"median":-6.708886,"eighty":-5.988933,"marketCap":883175015.23},{"date":"2024-06-14","current":-5.042271,"twenty":-8.277827,"median":-6.681503,"eighty":-5.938296,"marketCap":801878490.85},{"date":"2024-06-21","current":-5.510725,"twenty":-8.253084,"median":-6.681503,"eighty":-5.777439,"marketCap":872433075.44},{"date":"2024-06-28","current":-4.974132,"twenty":-8.244837,"median":-6.681503,"eighty":-5.74004,"marketCap":786723361.52},{"date":"2024-07-05","current":-5.306309,"twenty":-8.203599,"median":-6.667811,"eighty":-5.629968,"marketCap":847517911.35},{"date":"2024-07-12","current":-5.408517,"twenty":-8.118374,"median":-6.619891,"eighty":-5.595899,"marketCap":868631706.71},{"date":"2024-07-15","current":-5.417034,"twenty":-8.099129,"median":-6.613045,"eighty":-5.590788,"marketCap":873513053.92},{"date":"2024-08-02","current":-4.676203,"twenty":-8.079885,"median":-6.609622,"eighty":-5.583974,"marketCap":745105907.03},{"date":"2024-08-09","current":-4.513478,"twenty":-8.008406,"median":-6.578816,"eighty":-5.515836,"marketCap":727494223.22},{"date":"2024-08-16","current":-4.316495,"twenty":-7.986412,"median":-6.534318,"eighty":-5.490284,"marketCap":700482151.8},{"date":"2024-08-23","current":-4.453526,"twenty":-7.978164,"median":-6.503512,"eighty":-5.44429,"marketCap":730827498.61},{"date":"2024-08-30","current":-4.898879,"twenty":-7.906686,"median":-6.449861,"eighty":-5.413627,"marketCap":801684090.61},{"date":"2024-09-06","current":-4.667638,"twenty":-7.862699,"median":-6.432827,"eighty":-5.36082,"marketCap":764519824.83},{"date":"2024-09-13","current":-3.822511,"twenty":-7.855735,"median":-6.332367,"eighty":-5.335268,"marketCap":748409890.75},{"date":"2024-09-20","current":-3.623827,"twenty":-7.841256,"median":-6.30817,"eighty":-5.285867,"marketCap":716147844.73},{"date":"2024-09-27","current":-3.630961,"twenty":-7.835207,"median":-6.291292,"eighty":-5.156403,"marketCap":720043812.45},{"date":"2024-10-04","current":-3.210083,"twenty":-7.830393,"median":-6.281546,"eighty":-4.898879,"marketCap":627325694.46},{"date":"2024-10-11","current":-2.96041,"twenty":-7.805992,"median":-6.132492,"eighty":-4.671064,"marketCap":573856377.14},{"date":"2024-10-18","current":-3.434789,"twenty":-7.774725,"median":-6.075649,"eighty":-4.6094,"marketCap":659899758.53},{"date":"2024-10-25","current":-3.324219,"twenty":-7.75548,"median":-6.033455,"eighty":-4.49121,"marketCap":637070240.87},{"date":"2024-10-31","current":-3.438356,"twenty":-7.738985,"median":-6.030284,"eighty":-4.463804,"marketCap":662378132.46},{"date":"2024-11-08","current":-3.427655,"twenty":-7.738985,"median":-5.993854,"eighty":-4.429546,"marketCap":655972131.38},{"date":"2024-11-15","current":-3.106647,"twenty":-7.711493,"median":-5.970662,"eighty":-4.328485,"marketCap":583153684.93},{"date":"2024-11-22","current":-3.010345,"twenty":-7.590528,"median":-5.940851,"eighty":-3.765459,"marketCap":560275247.04},{"date":"2024-11-29","current":-2.837956,"twenty":-7.546541,"median":-5.882667,"eighty":-3.688029,"marketCap":531199944.09},{"date":"2024-12-06","current":-2.848666,"twenty":-7.379774,"median":-5.732176,"eighty":-3.623827,"marketCap":534218918.72},{"date":"2024-12-13","current":-2.548806,"twenty":-7.311316,"median":-5.65552,"eighty":-3.566759,"marketCap":474325506.61},{"date":"2024-12-20","current":-2.520248,"twenty":-7.311316,"median":-5.604416,"eighty":-3.452623,"marketCap":464239022.01},{"date":"2024-12-27","current":-2.516678,"twenty":-7.267503,"median":-5.595899,"eighty":-3.437643,"marketCap":465029850.03},{"date":"2025-01-03","current":-2.49883,"twenty":-7.157971,"median":-5.578864,"eighty":-3.421948,"marketCap":454676281.41},{"date":"2025-01-10","current":-2.309632,"twenty":-7.081298,"median":-5.52776,"eighty":-3.400548,"marketCap":421851498.87},{"date":"2025-01-17","current":-2.156736,"twenty":-7.048438,"median":-5.506467,"eighty":-3.355607,"marketCap":393925230.6},{"date":"2025-01-24","current":-2.178161,"twenty":-7.018316,"median":-5.493691,"eighty":-3.318513,"marketCap":402353167.1},{"date":"2025-01-31","current":-2.156736,"twenty":-6.993672,"median":-5.459621,"eighty":-3.135894,"marketCap":398893952.88},{"date":"2025-02-07","current":-2.038902,"twenty":-6.982711,"median":-5.442586,"eighty":-3.053859,"marketCap":375339390.95},{"date":"2025-02-14","current":-2.431685,"twenty":-6.966258,"median":-5.417034,"eighty":-3.014625,"marketCap":450591803.66},{"date":"2025-02-21","current":-2.725249,"twenty":-6.900568,"median":-5.408517,"eighty":-2.924742,"marketCap":505993414.61},{"date":"2025-02-28","current":-2.478798,"twenty":-6.859493,"median":-5.361671,"eighty":-2.877224,"marketCap":457649034.34},{"date":"2025-03-07","current":-2.62524,"twenty":-6.859493,"median":-5.348896,"eighty":-2.848666,"marketCap":504421902.75},{"date":"2025-03-14","current":-1.950178,"twenty":-6.845802,"median":-5.331861,"eighty":-2.792772,"marketCap":375893933.73},{"date":"2025-03-21","current":-2.425222,"twenty":-6.818419,"median":-5.306309,"eighty":-2.725249,"marketCap":466899893.66},{"date":"2025-03-28","current":-2.16502,"twenty":-6.797881,"median":-5.23817,"eighty":-2.643099,"marketCap":411881933.29},{"date":"2025-04-04","current":-1.798189,"twenty":-6.791035,"median":-5.118927,"eighty":-2.598783,"marketCap":350804145.45},{"date":"2025-04-11","current":-1.7874,"twenty":-6.777344,"median":-4.936505,"eighty":-2.541667,"marketCap":352326323.68},{"date":"2025-04-17","current":-1.884502,"twenty":-6.777344,"median":-4.813235,"eighty":-2.527388,"marketCap":377676205.37},{"date":"2025-04-25","current":-2.187427,"twenty":-6.755438,"median":-4.676203,"eighty":-2.49883,"marketCap":437738722.61},{"date":"2025-05-02","current":-2.334934,"twenty":-6.749961,"median":-4.641945,"eighty":-2.473083,"marketCap":464043181.1},{"date":"2025-05-09","current":-2.219807,"twenty":-6.744484,"median":-4.599123,"eighty":-2.430392,"marketCap":441113036.42},{"date":"2025-05-16","current":-1.936126,"twenty":-6.732161,"median":-4.504914,"eighty":-2.406016,"marketCap":381685399.33},{"date":"2025-05-23","current":-1.820966,"twenty":-6.723946,"median":-4.470655,"eighty":-2.350016,"marketCap":362101694.69},{"date":"2025-05-30","current":-1.900139,"twenty":-6.714362,"median":-4.462091,"eighty":-2.329767,"marketCap":380507035.56},{"date":"2025-06-06","current":-2.513168,"twenty":-6.708886,"median":-4.444961,"eighty":-2.329767,"marketCap":534533766.17},{"date":"2025-06-13","current":-1.97798,"twenty":-6.692456,"median":-4.410704,"eighty":-2.276706,"marketCap":425231303.24},{"date":"2025-06-20","current":-1.793505,"twenty":-6.681503,"median":-4.342188,"eighty":-2.264946,"marketCap":382035064.22},{"date":"2025-06-24","current":-1.913072,"twenty":-6.681503,"median":-4.325059,"eighty":-2.254542,"marketCap":413238223.05}],"updateTime":1750841705169}}}